Matthias Stelljes
0000-0002-9331-5145
Publication & Citation Trends
Most Cited Works
Publications
521 total
GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany PDF
Cited by 211
OpenAlex
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN) PDF
Cited by 545
OpenAlex
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study PDF
Cited by 320
OpenAlex
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
Cited by 348
OpenAlex
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) PDF
Cited by 241
OpenAlex
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia PDF
Cited by 1,342
OpenAlex
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
Cited by 656
OpenAlex
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL PDF
Cited by 466
OpenAlex
Research Topics
Acute Myeloid Leukemia Research
(240)
Acute Lymphoblastic Leukemia research
(239)
Hematopoietic Stem Cell Transplantation
(222)
Chronic Myeloid Leukemia Treatments
(136)
CAR-T cell therapy research
(93)
Frequent Co-Authors
Affiliations
Goethe University Frankfurt
Hudson Institute
Universität Hamburg
Philipps University of Marburg
Universität Ulm